SCHEMBL9379367

SCHEMBL9379367

C#CCN1C(=O)C2(CCCC2)c2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ OPRL1 P41146 10/20 0.48
▸ ALDH1A1 P00352 6/20 0.45
▸ GAA P10253 2/20 0.45
▸ MAOA P21397 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ OPRM1 P35372 5/20 0.44
▸ OPRK1 P41145 4/20 0.44
▸ KMT2A Q03164 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ C5AR1 P21730 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11640576 0.85 OPRL1 (0.48) OPRL1ALDH1A1OPRM1OPRK1SLC6A4
SCHEMBL11640983 0.78 OPRL1 (0.53) OPRL1OPRM1OPRK1LMNASLC6A4
SCHEMBL28393240 0.77 MAOA (0.47) ALDH1A1GAAMAOAMAOBKMT2A
SCHEMBL25502421 0.77 TP53 (0.48) ALDH1A1GAAMAOAMAOBKMT2A
SCHEMBL23991954 0.77 OPRL1 (0.48) OPRL1ALDH1A1OPRM1OPRK1SLC6A4
SCHEMBL12659470 0.77 L3MBTL1 (0.61) OPRL1ALDH1A1GAAOPRM1OPRK1
SCHEMBL11640502 0.75 LMNA (0.49) OPRL1OPRM1OPRK1LMNASLC6A4
SCHEMBL11636971 0.75 ALDH1A1 (0.54) OPRL1ALDH1A1OPRM1OPRK1LMNA
SCHEMBL11640010 0.74 SLC6A4 (0.57) OPRL1OPRM1OPRK1LMNASLC6A4
SCHEMBL23993157 0.73 OPRL1 (0.48) OPRL1ALDH1A1OPRM1OPRK1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0320992-B1 Triazolodiazepine derivatives HOFFMANN LA ROCHE (CH) 1994-07-27 — — EP disclosed
US-4959361-A Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists HOFFMANN-LA ROCHE INC. (US) 1990-09-25 — — US disclosed
EP-0320992-A2 Triazolodiazepine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-06-21 — — EP disclosed
Send feedback